Gri Bio Inc. has announced an increase in the number of shares available for issuance under its At The Market Offering Agreement with H.C. Wainwright & Co., LLC. The company has filed a prospectus supplement to raise the maximum number of shares of its common stock, with a par value of $0.0001 per share. The new aggregate total of shares available for issuance is valued at up to $1,758,934. This is in addition to shares already sold under the agreement, which have an aggregate gross sales price of approximately $4,546,137. Legal opinions regarding the issuance and sale of these shares have been provided by Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.